Astellas Pharma ADR (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 0 | 3,489,979 | 0 | 0 |
| Cost of Goods | N/A | N/A | 654,320 | N/A | N/A |
| Gross Profit | N/A | N/A | 2,835,658 | N/A | N/A |
| Operating Expenses | 0 | 0 | 2,065,870 | 0 | 0 |
| Operating Income | N/A | N/A | 770,109 | N/A | N/A |
| Interest Expense | 0 | 0 | 40,696 | 0 | 0 |
| Other Income | 0 | 0 | -105,542 | 0 | 0 |
| Pre-tax Income | 0 | 0 | 623,870 | 0 | 0 |
| Income Tax | N/A | N/A | 151,759 | N/A | N/A |
| Net Income Continuous | N/A | N/A | 472,112 | N/A | N/A |
| Net Income | $N/A | $N/A | $472,112 | $N/A | $N/A |
| EPS Basic Total Ops | N/A | N/A | 0.26 | N/A | N/A |
| EPS Basic Continuous Ops | N/A | N/A | 0.26 | N/A | N/A |
| EPS Diluted Total Ops | N/A | N/A | 0.26 | N/A | N/A |
| EPS Diluted Continuous Ops | N/A | N/A | 0.26 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | 0.44 | 0.30 | 0.40 | 0.30 | 0.13 |
| EBITDA(a) | $N/A | $N/A | $1,099,957 | $N/A | $N/A |